Stuart D. Flynn

3.1k total citations
60 papers, 2.3k citations indexed

About

Stuart D. Flynn is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stuart D. Flynn has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stuart D. Flynn's work include Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Stuart D. Flynn is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Stuart D. Flynn collaborates with scholars based in United States, Italy and Canada. Stuart D. Flynn's co-authors include Samuel A. Yousem, Leslie M. Scoutt, Shirley McCarthy, Barbara K. Kinder, Linda D. Shortliffe, Thomas A. Stamey, Daniel Luthringer, Bruce G. Haffty, Robert N. Troiano and T R McCauley and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Stuart D. Flynn

60 papers receiving 2.3k citations

Peers

Countries citing papers authored by Stuart D. Flynn

Since Specialization

Citations

This map shows the geographic impact of Stuart D. Flynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart D. Flynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart D. Flynn more than expected).

Fields of papers citing papers by Stuart D. Flynn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart D. Flynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart D. Flynn. The network helps show where Stuart D. Flynn may publish in the future.

Co-authorship network of co-authors of Stuart D. Flynn

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart D. Flynn. A scholar is included among the top collaborators of Stuart D. Flynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart D. Flynn. Stuart D. Flynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19 2022 ·SHILAP Revista de lepidopterología ·Farhad Khimani, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anish Ray, (unknown), Stuart D. Flynn, Gregory Y.H. Lip, (unknown), (unknown)	1
2	The mechanistic basis linking cytokine storm to thrombosis in COVID-19 2022 ·SHILAP Revista de lepidopterología ·(unknown), Farhad Khimani, (unknown), (unknown), (unknown), Anish Ray, (unknown), Stuart D. Flynn, Gregory Y.H. Lip, (unknown), (unknown)	8
3	Phoenix Rises, with Tucsonʼs Help: Establishing the First Four-Year Allopathic Program in the Nationʼs Fifth Largest City 2007 ·Academic Medicine ·Keith A. Joiner, (unknown), T. Philip Malan, Stuart D. Flynn, (unknown)	5
4	Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma 1 2004 ·Journal of the American College of Surgeons ·Stephan Ariyan, Charlotte E. Ariyan, Leonard R. Farber, David S. Fischer, Stuart D. Flynn, (unknown)	26
5	Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women 2004 ·Cancer Causes & Control ·Yawei Zhang, Theodore R. Holford, Brian P. Leaderer, Shelia Hoar Zahm, Peter Boyle, Lindsay M. Morton, Bing Zhang, Kaiyong Zou, Stuart D. Flynn, Giovanni Tallini, Patricia H. Owens, Tongzhang Zheng	126
6	Familial medullary thyroid carcinoma: Presymptomatic diagnosis and management in children 1999 ·The Journal of Pediatrics ·Rubina A. Heptulla, Robert P. Schwartz, A. Bale, Stuart D. Flynn, Myron Genel	27
7	Cystic adenomyosis of the uterus: MRI 1998 ·Journal of Magnetic Resonance Imaging ·Robert N. Troiano, Stuart D. Flynn, Shirley McCarthy	40
8	Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer. 1997 ·Journal of Clinical Oncology ·John R. Murren, Shannon W. Anderson, (unknown), G Pizzorno, Daniel J. Belliveau, Daniel Zelterman, Barbara Burtness, Irena Tocino, Stuart D. Flynn, David Beidler, Yi-Ting Cheng	35
9	Fibroma and fibrothecoma of the ovary: MR imaging findings. 1997 ·Radiology ·Robert N. Troiano, (unknown), Leslie M. Scoutt, Robert Lange, Stuart D. Flynn, (unknown)	108
10	Malignant Peripheral Nerve Sheath Tumor of the Orbit in a Newborn: a Case Report and Review 1997 ·Journal of Pediatric Ophthalmology & Strabismus ·John P. Fezza, (unknown), Stuart D. Flynn	3
11	Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study 1996 ·International Journal of Radiation OncologyBiologyPhysics ·Bruce G. Haffty, Felix Brown, Darryl Carter, Stuart D. Flynn	68
12	Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein 1996 ·Surgery ·(unknown), Eugene A. Cornelius, Sami S. Zoghbi, John R. Murren, Rola A.D. Ghoussoub, Stuart D. Flynn, Barbara K. Kinder	46
13	Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer 1996 ·Cancer Chemotherapy and Pharmacology ·John R. Murren, Henry J. Durivage, Antônio C. Buzaid, Michael Reiß, Stuart D. Flynn, Darryl Carter, William N. Hait	27
14	Efficacy of Transcutaneous Computed Tomography‐Guided Fine Needle Aspiration Biopsy in Patients With Laryngeal Squamous Cell Carcinoma, Probable Failed Radiation Therapy, and Negative Transmucosal Biopsies 1996 ·The Laryngoscope ·Martin J. Citardi, James J. Abrahams, Stuart D. Flynn, Clarence T. Sasaki	4
15	Ovarian Serous Borderline Tumors with Lymph Node Involvement Clinicopathologic and DNA Content Study of Seven Cases and Review of the Literature 1994 ·The American Journal of Surgical Pathology ·(unknown), Stuart D. Flynn, M.L. Carcangiu	46
16	Benign trichogenic tumours: a report of two cases supporting a simplified nomenclature 1993 ·Histopathology ·(unknown), Jon A. Reed, Saul Suster, Stuart D. Flynn, Martín C. Mihm	13
17	Local recurrence versus new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting 1993 ·International Journal of Radiation OncologyBiologyPhysics ·Bruce G. Haffty, Darryl Carter, Stuart D. Flynn, Diana Fischer, Douglas E. Brash, Jeffrey S. Simons, Annemarie Ziegler, James J. Fischer	83
18	Prognostic Significance of Tumor Proliferative Fraction and DNA Content in Stage I Non-Small Cell Lung Cancer 1992 ·American Review of Respiratory Disease ·Andrew E. Filderman, Gerard A. Silvestri, Constantine Gatsonis, Daniel Luthringer, (unknown), Stuart D. Flynn	28
19	Pulmonary meningiomas: A report of two cases 1991 ·Human Pathology ·Stuart D. Flynn, Samuel A. Yousem	19
20	Autoimmune Thyroid Disease: Immunological, Pathological, and Clinical Aspects 1988 ·CRC Critical Reviews in Clinical Laboratory Sciences ·Jack R. Wall, Stuart D. Flynn, Ronald H. Nishiyama, S. Thomas Bigos	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact